Nucala 100 MG/ML auto-injectorml
Ended Awarded
- Contract number
- SPE2DB25FZG16
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $5,679
Award facts
- Contract value 100% obligated
- $5,678.70 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $5,678.70 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of NUCALA 100 MG/ML auto-injectors. This delivery order, issued on June 18, 2025, with an ultimate completion date of June 20, 2025, represents a time-sensitive pharmaceutical procurement executed without a set-aside designation. The award falls under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with DLA valued at $499,999,999 through November 2026, which authorizes the agency to issue firm fixed-price delivery orders for comprehensive pharmaceutical products and medical supplies supporting military health facilities worldwide.
NUCALA (mepolizumab) is a biologic medication used to treat eosinophilic conditions, and this delivery order facilitates the DLA's procurement of auto-injector formulations to support Department of Defense healthcare operations. DMS Pharmaceutical Group has established itself as a critical supplier within the federal pharmaceutical supply chain, consistently securing contracts across diverse product categories including specialty medications, biologics, and prescription drugs. The company's robust portfolio of federal awards and established distribution capabilities position it as a key vendor for meeting urgent pharmaceutical supply requirements across military medical facilities.
Quick answers
Who was awarded contract SPE2DB25FZG16?
SPE2DB25FZG16 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on June 18, 2025.
How much is contract SPE2DB25FZG16 worth?
The government has obligated $5,679 on SPE2DB25FZG16.
Is contract SPE2DB25FZG16 an order under another contract?
Yes. SPE2DB25FZG16 is a delivery order under SPE2DB22D9205, an indefinite delivery contract.
Was contract SPE2DB25FZG16 competed?
The extent of competition for SPE2DB25FZG16 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award